Osimertinib, a novel targeted therapy, has emerged as a groundbreaking treatment for glioblastoma, a highly aggressive form of brain cancer. This drug, specifically designed to target the EGFR mutation, has shown promising results in clinical trials, offering new hope for glioblastoma patients. This article delves into the mechanism of action of osimertinib in glioblastoma, its clinical...